Mark Parry Billings
Direktor/Vorstandsmitglied bei Atopix Therapeutics Ltd.
Ursprung des Netzwerks ersten Grades von Mark Parry Billings
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Atopix Therapeutics Ltd.
 Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mark Parry Billings
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Orca Pharmaceuticals Ltd.
 Orca Pharmaceuticals Ltd. BiotechnologyHealth Technology Orca Pharmaceuticals Ltd. operates as a biotechnology company that develops oral drugs for the treatment of chronic inflammatory diseases. It also develops oral drug for the treatment a spectrum of autoimmune diseases that includes psoriasis, ankylosing spondylitis and inflammatory bowel disease. The company was founded by Michael Hunter, Roy Pettipher, Dan Littman, and Jun R. Huh in 2012 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Founder Chief Executive Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Wellcome Plc
 Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| VERNALIS | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Vereinigtes Königreich | 5 |
| Vereinigte Staaten | 3 |
Sektoral
| Health Technology | 5 |
| Commercial Services | 2 |
| Process Industries | 2 |
Operativ
| Corporate Officer/Principal | 6 |
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Roy Pettipher | 5 |
| Michael Hunter | 5 |
- Börse
- Insiders
- Mark Parry Billings
- Unternehmensverbindungen
